This website will be unavailable from Friday, April 26, 2024 at 6:00 p.m. through Monday, April 29, 2024 at 7:00 a.m. due to data center maintenance.

 
 
  By: Burrows H.B. No. 4002
 
 
 
A BILL TO BE ENTITLED
 
AN ACT
  relating to an interim study regarding international price
  discrimination in pharmaceuticals.
         BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
         SECTION 1.  INTERIM COMMITTEE; STUDY.  (a)  The joint interim
  committee on pharmaceutical pricing is established to study and
  review the impacts of international pharmaceutical price
  discrimination on the people of Texas as well as on the state
  government.
         (b)  The study must consider:
               (1)  the reasoning behind pharmaceutical companies
  pricing on the international market;
               (2)  any changes in the cost of pharmaceuticals under
  the Affordable Care Act;
               (3)  the amount to which the American public subsidizes
  the international pharmaceutical market, research and development,
  and other costs; and
               (4)  the impacts of price discrimination on:
                     (A)  individual citizens of this state; and
                     (B)  the budget of this state;
         (c)  The joint interim committee shall be composed of the
  members of the international trade and intergovernmental affairs
  committee of the house of representatives, and the
  intergovernmental relations committee of the senate.
         (d)  The chairmen of each respective committee shall serve as
  co-chairs for the joint interim committee.
         (e)  The joint interim committee shall convene at the call of
  one of the co-chairs.
         (f)  The joint interim committee has all other powers and
  duties provided to a special or select committee by the rules of the
  senate and house of representatives, by Subchapter B, Chapter 301,
  Government Code, and by policies of the senate and house committees
  on administration.
         (g)  Not later than January 6, 2017, the joint interim
  committee shall report the committee's findings to the lieutenant
  governor, the speaker of the house of representatives, and the
  governor.
         (h)  From the contingent expense fund of the senate and the
  contingent expense fund of the house of representatives equally,
  the members of the joint interim committee shall be reimbursed for
  expenses incurred in carrying out the provisions of this Act in
  accordance with the senate and house of representatives rules of
  procedure and the policies of the committees on administration.
  Other necessary expenses of operation shall be paid from the
  contingent expense fund of the senate and the contingent expense
  fund of the house of representatives equally.
         (i)  The Texas Legislative Council shall provide legal and
  policy research, bill drafting, and statistical analysis services
  to the committee created under this section.
         SECTION 2.  ABOLITION OF COMMITTEE.  The committee is
  abolished and this Act expires January 12, 2017.
         SECTION 3.  EFFECTIVE DATE. This Act takes effect
  immediately if it receives a vote of two-thirds of all the members
  elected to each house, as provided by Section 39, Article III, Texas
  Constitution. If this Act does not receive the vote necessary for
  immediate effect, this Act takes effect September 1, 2015.